Telcare’s next-generation wireless blood glucose meter – the Telcare BGM has now been certified to operate on Verizon’s nationwide cellular network. The product was developed in collaboration with both Verizon and Qualcomm, Inc., and is the first medical device to utilize Qualcomm’s new Internet of Everything module. Telcare’s product is the first technology to make CDMA connectivity affordable for consumer-focused medical devices. The product will be exhibited in Telcare’s booth, located inside the Qualcomm Life Pavilion #26715 at the 2013 Consumer Electronics Show.
The Telcare product will operate with both Telcare’s FDA-cleared diabetes management portal and with other soon-to-be released mHealth care management platforms. By integrating Telcare’s FDA-cleared blood glucose meter and cloud server to the Verizon network, people with diabetes, their families, and their health professionals will now be able to integrate real-time measurement of blood glucose levels with other physiologic parameters, such as weight and blood pressure.
“Telcare is excited to establish this collaboration as it will enable us to better support Americans with diabetes, their loved ones, and their medical caregivers. Moreover, the outstanding cellular coverage afforded nationwide by Verizon wireless will be particularly valuable in continuously connecting people with diabetes to their care system,” said Jonathan C. Javitt, M.D., M.P.H., Telcare’s CEO and co-founder.
Diabetes mellitus affects 32 million Americans and the Centers for Disease Control (CDC) estimates that one in three Americans born after 2000 will have the condition. Although the complications of diabetes can be prevented through daily monitoring and control of blood sugar, diabetes today accounts for one in ten healthcare dollars spent in the U.S. and results in needless strokes, heart attacks, amputations and cases of blindness.
Telcare BGM is a registered trademark of Telcare, Inc.